0001140361-12-034600.txt : 20120801
0001140361-12-034600.hdr.sgml : 20120801
20120801151814
ACCESSION NUMBER: 0001140361-12-034600
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120731
FILED AS OF DATE: 20120801
DATE AS OF CHANGE: 20120801
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDTOX SCIENTIFIC INC
CENTRAL INDEX KEY: 0000739944
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 953863205
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 402 WEST COUNTY ROAD D
CITY: ST PAUL
STATE: MN
ZIP: 55112
BUSINESS PHONE: 6126367466
MAIL ADDRESS:
STREET 1: 402 WEST COUNTY ROAD D
CITY: ST PAUL
STATE: MN
ZIP: 55112
FORMER COMPANY:
FORMER CONFORMED NAME: EDITEK INC
DATE OF NAME CHANGE: 19940902
FORMER COMPANY:
FORMER CONFORMED NAME: ENVIRONMENTAL DIAGNOSTICS INC
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WIERSMA KEVIN J
CENTRAL INDEX KEY: 0001187451
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11394
FILM NUMBER: 12999862
MAIL ADDRESS:
STREET 1: 402 WEST COUNTY RD D
CITY: ST PAUL
STATE: MN
ZIP: 55112
4
1
doc1.xml
FORM 4
X0306
4
2012-07-31
1
0000739944
MEDTOX SCIENTIFIC INC
MTOX
0001187451
WIERSMA KEVIN J
402 WEST COUNTY ROAD D
ST PAUL
MN
55112
0
1
0
0
V.P., COO-Labs, and CFO
Common Stock
2012-07-31
4
D
0
86917
27.00
D
34210
D
Common Stock
2012-07-31
4
D
0
30045
27.00
D
4165
D
Common Stock
2012-07-31
4
D
0
4165
27.00
D
0
D
Non-Qualified Stock Option (right to buy)
3.70
2012-07-31
4
D
0
30000
27.00
D
2003-09-11
2013-12-31
Common Stock
30000
0
D
Non-Qualified Stock Option (right to buy)
4.4067
2012-07-31
4
D
0
15000
27.00
D
2003-01-01
2013-01-01
Common Stock
15000
0
D
Disposition is exempt under Rule 16(b)(3)
Disposed of pursuant to merger agreement between issuer and Laboratory Corporation of America Holdings in exchange for $27.00 per share cash.
Attributable to non-qualified deferred compensation plan.
This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $23.30, representing the difference between the exercise price of the option and the $27.00 per share merger consideration.
This option, which is fully vested, was canceled in the merger in exchange for a cash payment of $25.5933, representing the difference between the exercise price of the option and the $27.00 per share merger consideration.
Kevin J Wiersma
2012-08-01